Veramedika - Company finances
|
EUR
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 0 | 1,991 | 2,175 | 2,243 |
| Profit before tax | -375 | 129 | 533 | 847 |
| Net profit | -375 | 122 | 506 | 796 |
| Equity | 50 | 172 | 678 | 1,474 |
| Liabilities | 0 | 152 | 48 | 270 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 50 | 324 | 726 | 1,744 |
| Total assets | 50 | 324 | 726 | 1,744 |
|
Taxes paid
|
||||
| STI taxes | - | 50 | 6 | 27 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +9.2% | +3.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -750.0% | 37.7% | 69.7% | 45.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -750.0% | 70.9% | 74.6% | 54.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 6.1% | 23.3% | 35.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 6.5% | 24.5% | 37.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.9 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Veramedika - Social security debts
The company had no debts to Sodra
Veramedika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-27 | 2026-04-27 | 0.16 |
| 2026-03-20 | 2026-03-26 | 0.32 |
| 2025-08-01 | 2026-03-19 | 0.16 |
| 2025-07-03 | 2025-07-31 | 0.14 |
| 2025-07-01 | 2025-07-02 | 27.14 |
| 2025-06-19 | 2025-06-30 | 27.0 |
| 2024-06-20 | 2024-10-16 | 6.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Veramedika, MB, company code 155323121, is a Small partnership operating in residential nursing care activities. In 2025, it generated revenue of €2.2K, slightly above €2.2K in 2024 and €2.0K in 2023, showing a steady but modest growth trend. Net profit improved from €122 in 2023 to €506 in 2024 and €796 in 2025, while the profit margin increased to 35.5% in the latest year. The reported revenue growth was +3.1% year on year and +12.7% over two years. The balance sheet also expanded materially: total assets rose from €324 in 2023 to €726 in 2024 and €1.7K in 2025, with equity increasing to about €1.5K and liabilities at €270. The equity ratio was 84.5% and debt-to-equity 0.18, indicating a low-leverage structure. Asset turnover reached 1.29x, and return indicators remained strong, although they should be viewed in the context of the company’s very small scale.